Pipelines under development

Code/ Nonproprietary Name Indication Basic research Non-clinical study Clinical study
Phase I Phase II License out
① LT-1001/ PC-SOD
  【iv】
(DDS technology)
UC Beijing Tide
(Aug. 2007)
IPF Beijing Tide
(Aug. 2007)
Acute respiratory distress syndrome
Stroke and MI Beijing Tide
(Aug. 2007)
② LT-1002/ PC-SOD NE
  【Nebulizer】
(DDS technology)
IPF CKD
(Aug. 2011)
COPD
③ LT-2001/ AS-013
(DDS technology)
chronic arterial occlusive disease Beijing Tide
(Sep. 2009)
④LT-2003/ Nano-PGE1
(DDS technology)
chronic arterial occlusive disease Beijing Tide
(Nov. 2010)
⑤ LT-2004/ Nano-BPS
(DDS technology)
Pulmonary arterial hypertension
⑥ LT-3001/ NSAID
(new chemical)
Inflammatory disease
⑦ LT-3002
(new chemical)
COPD
⑧ LT-4001/
Drug re-positioning (DR)
COPD
⑨ LT-4002, LT-4003/
Drug re-positioning (DR)
Dry eye
⑩ LT-4004/
  Drug re-positioning (DR)
EA Pharma
(Oct. 2015)
⑪ LT-4005/
  Drug re-positioning (DR)
FD
⑫ LT-4006/
  Drug re-positioning (DR)
IBS
⑬ LT-4007/
  Drug re-positioning (DR)
Neurodegenerative
disease
⑭ LT-4008/
  Drug re-positioning (DR)
Cancer